help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houck, K. A.
Right arrow Articles by Leung, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houck, K. A.
Right arrow Articles by Leung, D. W.

Molecular Endocrinology, Vol 5, 1806-1814, Copyright © 1991 by Endocrine Society

ARTICLES

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA

KA Houck, N Ferrara, J Winer, G Cachianes, B Li and DW Leung
Department of Molecular Biology, Genetech, Inc., South San Francisco, California 94080.

Vascular endothelial growth factor (VEGF) was recently identified as a secreted, direct-acting mitogen specific for vascular endothelial cells and capable of stimulating angiogenesis in vivo. Molecular cloning revealed multiple forms of VEGF, apparently arising from alternative splicing of its RNA transcript. We have examined various human cDNA libraries by the polymerase chain reaction technique and discovered a fourth molecular form, VEGF206. This form contains a 41-amino acid insertion relative to the most abundant form, VEGF165, and includes the highly basic 24-amino acid insertion found in VEGF189. Southern blot analysis revealed that a single gene encoded these various forms, and nucleic acid sequence analysis of a portion of the VEGF gene revealed an intron/exon structure compatible with alternative splicing of RNA as a mechanism for their generation. Transient transfection of human embryonic kidney 293 cells showed that, like VEGF189, VEGF206 was predominately cell-associated and only very poorly secreted despite the presence of the signal peptide identical to that found in VEGF121 and VEGF165, both of which are efficiently exported from the cell. Vascular permeability activity was detected in the medium of 293 cells transfected with all four forms of VEGF; however, endothelial cell mitogenic activity was apparent only with VEGF121 and VEGF165. Thus, alternative splicing of VEGF RNA can produce four polypeptides with strikingly different secretion patterns, which suggests multiple physiological roles for this family of proteins.


This article has been cited by other articles:


Home page
 J. Virol.Home page
Z.-L. Wang, X.-P. Xu, B.-L. He, S.-P. Weng, J. Xiao, L. Wang, T. Lin, X. Liu, Q. Wang, X.-Q. Yu, et al.
Infectious Spleen and Kidney Necrosis Virus ORF48R Functions as a New Viral Vascular Endothelial Growth Factor
J. Virol., May 1, 2008; 82(9): 4371 - 4383.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. O. Weinzierl, D. Maurer, F. Altenberend, N. Schneiderhan-Marra, K. Klingel, O. Schoor, D. Wernet, T. Joos, H.-G. Rammensee, and S. Stevanovic
A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays
Cancer Res., April 1, 2008; 68(7): 2447 - 2454.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. Bastide, Z. Karaa, S. Bornes, C. Hieblot, E. Lacazette, H. Prats, and C. Touriol
An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform
Nucleic Acids Res., April 1, 2008; 36(7): 2434 - 2445.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Y. Qiu, H. Bevan, S. Weeraperuma, D. Wratting, D. Murphy, C. R Neal, D. O. Bates, and S. J. Harper
Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b
FASEB J, April 1, 2008; 22(4): 1104 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
P. Mineur, A. C. Colige, Christophe. F. Deroanne, J. Dubail, F. Kesteloot, Y. Habraken, A. Noel, S. Voo, J. Waltenberger, C. M. Lapiere, et al.
Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents
J. Cell Biol., December 17, 2007; 179(6): 1261 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Donnem, S. Al-Saad, K. Al-Shibli, M. P. Delghandi, M. Persson, M. N. Nilsen, L.-T. Busund, and R. M. Bremnes
Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non Small Cell Lung Cancer
Clin. Cancer Res., November 15, 2007; 13(22): 6649 - 6657.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
J. Dai and A.B.M. Rabie
VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification
J. Dent. Res., October 1, 2007; 86(10): 937 - 950.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
C. Gridelli, P. Maione, A. Rossi, and F. De Marinis
The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments
Oncologist, October 1, 2007; 12(10): 1183 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G. S. Robinson, Y.-S. Ng, and D. T. Shima
Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain
J. Biol. Chem., September 21, 2007; 282(38): 28045 - 28056.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Pan, Y. Chathery, Y. Wu, N. Rathore, R. K. Tong, F. Peale, A. Bagri, M. Tessier-Lavigne, A. W. Koch, and R. J. Watts
Neuropilin-1 Binds to VEGF121 and Regulates Endothelial Cell Migration and Sprouting
J. Biol. Chem., August 17, 2007; 282(33): 24049 - 24056.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Zygalaki, E. G. Tsaroucha, L. Kaklamanis, and E. S. Lianidou
Quantitative Real-Time Reverse Transcription PCR Study of the Expression of Vascular Endothelial Growth Factor (VEGF) Splice Variants and VEGF Receptors (VEGFR-1 and VEGFR-2) in Non Small Cell Lung Cancer
Clin. Chem., August 1, 2007; 53(8): 1433 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G.-S. Hwang, S.-W. Wang, W.-M. Tseng, C.-H. Yu, and P. S. Wang
Effect of hypoxia on the release of vascular endothelial growth factor and testosterone in mouse TM3 Leydig cells
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1763 - E1769.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. C. Lake, R. Vassy, M. Di Benedetto, D. Lavigne, C. Le Visage, G. Y. Perret, and D. Letourneur
Low Molecular Weight Fucoidan Increases VEGF165-induced Endothelial Cell Migration by Enhancing VEGF165 Binding to VEGFR-2 and NRP1
J. Biol. Chem., December 8, 2006; 281(49): 37844 - 37852.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. S. Mader, D. Smyth, J. Marshall, and D. W. Hoskin
Bovine Lactoferricin Inhibits Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor165-Induced Angiogenesis by Competing for Heparin-Like Binding Sites on Endothelial Cells
Am. J. Pathol., November 1, 2006; 169(5): 1753 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Kowanetz and N. Ferrara
Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective
Clin. Cancer Res., September 1, 2006; 12(17): 5018 - 5022.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J.-S. Choi, K.-B. Kim, W. Han, D. S. Kim, J. S. Park, J. J. Lee, and D. S. Lee
Efficacy of Therapeutic Angiogenesis by Intramyocardial Injection of pCK-VEGF165 in Pigs
Ann. Thorac. Surg., August 1, 2006; 82(2): 679 - 686.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. van de Langerijt, J. M. Gijtenbeek, H.P.M. de Reus, F. C.G.J. Sweep, A. Geurts-Moespot, J. C.M. Hendriks, A. C. Kappelle, and M. M. Verbeek
CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
Neurology, July 11, 2006; 67(1): 114 - 119.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Saint-Geniez, A. E. Maldonado, and P. A. D'Amore
VEGF Expression and Receptor Activation in the Choroid during Development and in the Adult.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3135 - 3142.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. Morabito, E. De Maio, M. Di Maio, N. Normanno, and F. Perrone
Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions
Oncologist, July 1, 2006; 11(7): 753 - 764.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Jia, A. Bagherzadeh, B. Hartzoulakis, A. Jarvis, M. Lohr, S. Shaikh, R. Aqil, L. Cheng, M. Tickner, D. Esposito, et al.
Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling
J. Biol. Chem., May 12, 2006; 281(19): 13493 - 13502.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
C. A. Glass, S. J. Harper, and D. O. Bates
The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo
J. Physiol., April 1, 2006; 572(1): 243 - 257.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
D. R. Yance Jr and S. M. Sagar
Targeting angiogenesis with integrative cancer therapies.
Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. Robinson, B. Mulloy, J. T. Gallagher, and S. E. Stringer
VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase
J. Biol. Chem., January 20, 2006; 281(3): 1731 - 1740.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Rouet, Y. Hamma-Kourbali, E. Petit, P. Panagopoulou, P. Katsoris, D. Barritault, J.-P. Caruelle, and J. Courty
A Synthetic Glycosaminoglycan Mimetic Binds Vascular Endothelial Growth Factor and Modulates Angiogenesis
J. Biol. Chem., September 23, 2005; 280(38): 32792 - 32800.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Zygalaki, A. Stathopoulou, C. Kroupis, L. Kaklamanis, Z. Kyriakides, D. Kremastinos, and E. S. Lianidou
Real-Time Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor Splice Variants
Clin. Chem., August 1, 2005; 51(8): 1518 - 1520.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. Gustafsson, H. Ameln, H. Fischer, C. J. Sundberg, J. A. Timmons, and E. Jansson
VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise
J Appl Physiol, June 1, 2005; 98(6): 2137 - 2146.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
S. Lee, S. M. Jilani, G. V. Nikolova, D. Carpizo, and M. L. Iruela-Arispe
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
J. Cell Biol., May 23, 2005; 169(4): 681 - 691.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X.-F. Wang, J. Z. Cui, S. S. Prasad, and J. A. Matsubara
Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1508 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Podar and K. C. Anderson
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
Blood, February 15, 2005; 105(4): 1383 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. J. Hicklin and L. M. Ellis
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027.
[Abstract] [Full Text] [PDF]

Home page
 Arch Facial Plast SurgHome page
J. D. Pollard, S. Quan, T. Kang, and R. J. Koch
Effects of Copper Tripeptide on the Growth and Expression of Growth Factors by Normal and Irradiated Fibroblasts
Arch Facial Plast Surg, January 1, 2005; 7(1): 27 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Woolard, W.-Y. Wang, H. S. Bevan, Y. Qiu, L. Morbidelli, R. O. Pritchard-Jones, T.-G. Cui, M. Sugiono, E. Waine, R. Perrin, et al.
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant: Mechanism of Action, In vivo Effect On Angiogenesis and Endogenous Protein Expression
Cancer Res., November 1, 2004; 64(21): 7822 - 7835.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Chen, Y. Kasama, J. S. Lee, B. Jim, M. Marin, and F. N. Ziyadeh
Podocyte-Derived Vascular Endothelial Growth Factor Mediates the Stimulation of {alpha}3(IV) Collagen Production by Transforming Growth Factor-{beta}1 in Mouse Podocytes
Diabetes, November 1, 2004; 53(11): 2939 - 2949.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Castro-Rivera, S. Ran, P. Thorpe, and J. D. Minna
Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect
PNAS, August 3, 2004; 101(31): 11432 - 11437.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Ferrara
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Endocr. Rev., August 1, 2004; 25(4): 581 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Jensen, H. Pilegaard, P. D. Neufer, and Y. Hellsten
Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R397 - R402.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. P. Bond, L. J. Parry, C. S. Samuel, H. M. Gehring, F. L. Lederman, P. A. W. Rogers, and R. J. Summers
Increased Expression of the Relaxin Receptor (LGR7) in Human Endometrium during the Secretory Phase of the Menstrual Cycle
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3477 - 3485.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
I. Friehs, A. M. Moran, C. Stamm, Y.-H. Choi, D. B. Cowan, F. X. McGowan, and P. J. del Nido
Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury
Ann. Thorac. Surg., June 1, 2004; 77(6): 2004 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J.-Y. Chung, Y. Song, Y. Wang, R. R. Magness, and J. Zheng
Differential Expression of Vascular Endothelial Growth Factor (VEGF), Endocrine Gland Derived-VEGF, and VEGF Receptors in Human Placentas from Normal and Preeclamptic Pregnancies
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2484 - 2490.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Bornes, M. Boulard, C. Hieblot, C. Zanibellato, J. S. Iacovoni, H. Prats, and C. Touriol
Control of the Vascular Endothelial Growth Factor Internal Ribosome Entry Site (IRES) Activity and Translation Initiation by Alternatively Spliced Coding Sequences
J. Biol. Chem., April 30, 2004; 279(18): 18717 - 18726.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Asosingh, H. De Raeve, E. Menu, I. Van Riet, E. Van Marck, B. Van Camp, and K. Vanderkerken
Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity
Blood, April 15, 2004; 103(8): 3131 - 3137.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. E. Konecny, Y. G. Meng, M. Untch, H.-J. Wang, I. Bauerfeind, M. Epstein, P. Stieber, J.-M. Vernes, J. Gutierrez, K. Hong, et al.
Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients
Clin. Cancer Res., March 1, 2004; 10(5): 1706 - 1716.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Ruiz, C. Pettaway, R. Song, O. Stoeltzing, L. Ellis, and M. Bar-Eli
Activator Protein 2{alpha} Inhibits Tumorigenicity and Represses Vascular Endothelial Growth Factor Transcription in Prostate Cancer Cells
Cancer Res., January 15, 2004; 64(2): 631 - 638.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Gogat, L. Le Gat, L. Van Den Berghe, D. Marchant, A. Kobetz, S. Gadin, B. Gasser, I. Quere, M. Abitbol, and M. Menasche
VEGF and KDR Gene Expression during Human Embryonic and Fetal Eye Development
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 7 - 14.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
X. Jiang and J. R. Couchman
Perlecan and Tumor Angiogenesis
J. Histochem. Cytochem., November 1, 2003; 51(11): 1393 - 1410.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. S. Huang, F.-M. Tang, Y.-H. Huang, I-H. Liu, S.-C. Hsu, S.-T. Chen, and J. S. Huang
Cloning, Expression, Characterization, and Role in Autocrine Cell Growth of Cell Surface Retention Sequence Binding Protein-1
J. Biol. Chem., October 31, 2003; 278(44): 43855 - 43869.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Liu, L. H. Cheung, P. Thorpe, and M. G. Rosenblum
Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: Directed apoptotic events in vascular endothelial cells
Mol. Cancer Ther., October 1, 2003; 2(10): 949 - 959.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
T. Shimizu, J.-Y. Jiang, K. Iijima, K. Miyabayashi, Y. Ogawa, H. Sasada, and E. Sato
Induction of Follicular Development by Direct Single Injection of Vascular Endothelial Growth Factor Gene Fragments into the Ovary of Miniature Gilts
Biol Reprod, October 1, 2003; 69(4): 1388 - 1393.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
B.A. Roopa, A. Loganath, and K. Singh
The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium
Hum. Reprod., September 1, 2003; 18(9): 1809 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
O. Stoeltzing, W. Liu, N. Reinmuth, A. Parikh, S. A. Ahmad, Y. D. Jung, F. Fan, and L. M. Ellis
Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver Metastasis
Ann. Surg. Oncol., August 1, 2003; 10(7): 722 - 733.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Mata-Greenwood, B. Meyrick, S. J. Soifer, J. R. Fineman, and S. M. Black
Expression of VEGF and its receptors Flt-1 and Flk-1/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L222 - L231.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
S. Turcotte, R. R. Desrosiers, and R. Beliveau
HIF-1{alpha} mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma
J. Cell Sci., June 1, 2003; 116(11): 2247 - 2260.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Louzier, B. Raffestin, A. Leroux, D. Branellec, J. M. Caillaud, M. Levame, S. Eddahibi, and S. Adnot
Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L926 - L937.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. R. Foster, R. Hole, K. Anderson, S. C. Satchell, R. J. Coward, P. W. Mathieson, D. A. Gillatt, M. A. Saleem, D. O. Bates, and S. J. Harper
Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes
Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1263 - F1273.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Lange, N. Guttmann-Raviv, L. Baruch, M. Machluf, and G. Neufeld
VEGF162, A New Heparin-binding Vascular Endothelial Growth Factor Splice Form That Is Expressed in Transformed Human Cells
J. Biol. Chem., May 2, 2003; 278(19): 17164 - 17169.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Sonoda, M. Kanamori, D. F. Deen, S.-Y. Cheng, M. S. Berger, and R. O. Pieper
Overexpression of Vascular Endothelial Growth Factor Isoforms Drives Oxygenation and Growth but not Progression to Glioblastoma Multiforme in a Human Model of Gliomagenesis
Cancer Res., April 15, 2003; 63(8): 1962 - 1968.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D.C Felmeden, A.D Blann, and G.Y.H Lip
Angiogenesis: basic pathophysiology and implications for disease
Eur. Heart J., April 1, 2003; 24(7): 586 - 603.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Benckert, S. Jonas, T. Cramer, Z. von Marschall, G. Schafer, M. Peters, K. Wagner, C. Radke, B. Wiedenmann, P. Neuhaus, et al.
Transforming Growth Factor {beta}1 Stimulates Vascular Endothelial Growth Factor Gene Transcription in Human Cholangiocellular Carcinoma Cells
Cancer Res., March 1, 2003; 63(5): 1083 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Y.-J. YIN, Z. SALAH, M. MAOZ, S. C. E. RAM, S. OCHAYON, G. NEUFELD, S. KATZAV, and R. BAR-SHAVIT
Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation
FASEB J, February 1, 2003; 17(2): 163 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
K. D. Burroughs, J. Oh, J. C. Barrett, and R. P. DiAugustine
Phosphatidylinositol 3-Kinase and Mek1/2 Are Necessary for Insulin-Like Growth Factor-I-Induced Vascular Endothelial Growth Factor Synthesis in Prostate Epithelial Cells: A Role for Hypoxia-Inducible Factor-1?
Mol. Cancer Res., February 1, 2003; 1(4): 312 - 322.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. M. Hastings, D. R. Licence, G. J. Burton, D. S. Charnock-Jones, and S. K. Smith
Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17{beta}-Estradiol in the Mouse Uterus
Endocrinology, January 1, 2003; 144(1): 326 - 334.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. Mulligan-Kehoe, H. K. Kleinman, M. Drinane, R. J. Wagner, C. Wieland, and R. J. Powell
A Truncated Plasminogen Activator Inhibitor-1 Protein Blocks the Availability of Heparin-binding Vascular Endothelial Growth Factor A Isoforms
J. Biol. Chem., December 6,